As a UK pharmacist, I understand the importance of providing accurate and accessible information to support your health decisions. Mounjaro, known generically as tirzepatide, is a medication approved in the UK for weight management and weight loss. It is also used to manage type 2 diabetes.
What is Mounjaro?
Mounjaro is a prescription-only medication that contains tirzepatide as its active ingredient. It is administered as a weekly subcutaneous injection. Mounjaro works by regulating blood sugar levels and suppressing appetite, which can lead to weight loss. It is typically prescribed for adults with a body mass index (BMI) of 30 or higher, or 27 with weight-related health conditions.
How Does Mounjaro Work?
Mounjaro functions by mimicking the action of two hormones, GIP and GLP-1, which play a role in regulating blood sugar and appetite. This dual action helps to lower blood sugar levels and reduce hunger, contributing to weight loss.
Efficacy and Benefits
Clinical studies have shown that Mounjaro can lead to significant weight loss. In a 72-week trial, participants lost an average of 23 kilograms, surpassing the results of other weight loss medications.
Administration
Mounjaro is administered via a subcutaneous injection once a week. The dosing regimen starts with an initial dose of 2.5 mg for four weeks, followed by incremental increases of 2.5 mg every four weeks, up to a maximum of 15 mg, as determined by a healthcare provider.
